> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# EUA for Cepheid Xpert Mpox Test
- URL: https://www.fdaweb.com/eua-for-cepheid-xpert-mpox-test/
- Published: 2023-02-10T12:00:00.000Z
- Updated: 2026-09-14T18:15:32.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5153754

FDA has issued an [emergency use authorization](https://www.fda.gov/medical-devices/emergency-use-authorizations-medical-devices/monkeypox-mpox-emergency-use-authorizations-medical-devices?ref=fdaweb.com) for the Cepheid Xpert Mpox test for use in a point-of-care setting for detecting monkeypox. “Validation data (were) gathered through the National Institutes of Health (NIH) Independent Test Assessment Program established as a collaboration between the FDA and the NIH,” the agency says. The real-time polymerase chain reaction test is intended to detect Mpox virus DNA in lesion swab specimens from individuals suspected of monkeypox by their health care provider.